• 1
    Andersen MH, Schrama D, Thor SP, Becker JC. Cytotoxic T cells. J Invest Dermatol 2006; 126:3241.
  • 2
    Nagata S. Fas-mediated apoptosis. Adv Exp Med Biol 1996; 406:11924.
  • 3
    Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76:97787.
  • 4
    Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2:73547.
  • 5
    Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 2003; 15:53343.
  • 6
    Schmitz JE, Kuroda MJ, Santra S et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:85760.
  • 7
    Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997; 187:187228.
  • 8
    Shearer GM, Levy RB. Noninfectious cofactors in susceptibility to AIDS: possible contributions of semen, HLA alloantigens, and lack of natural resistance. Ann N Y Acad Sci 1984; 437:4957.
  • 9
    Lee BN, Lu JG, Kline MW, Paul M, Doyle M, Kozinetz C, Shearer WT, Reuben JM. Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus. Clin Diagn Lab Immunol 1996; 3:4939.
  • 10
    Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23:51548.
  • 11
    Schoenberger SP, Toes RE, Van Der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions. Nature 1998; 393:4803.
  • 12
    O’Sullivan B, Thomas R. CD40 and dendritic cell function. Crit Rev Immunol 2003; 23:83107.
  • 13
    Rockstroh JK, Kruezer KA, Sauerbruch T, Spengler U. Protein levels of interleukin-12 p70 holomer, its p40 chain and interferon-gamma during advancing HIV infection. J Infect 1998; 37:2826.
  • 14
    Vanham G, Penne L, Devalck J, Kestens L, Colebunders R, Bosmans E, Thielemans K, Ceuppens JL. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol 1999; 117:33542.
  • 15
    Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, Trinchieri G. The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 1999; 94:100311.
  • 16
    Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, Hoelzer D, Rossol R. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997; 11:11118.
  • 17
    Oxenius A, Karrer U, Zinkernagel RM, Hengartner H. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J Immunol 1999; 162:96573.
  • 18
    Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186:3945.
  • 19
    Wang S, Pal R, Mascola JR et al. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology 2006; 350:3447.
  • 20
    Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandstrom E, Wahren B. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 1998; 351:13205.
  • 21
    Lole KS, Bollinger RC, Paranjape RS et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999; 73:15260.
  • 22
    Morikawa Y, Overton HA, Moore JP, Wilkinson AJ, Brady RL, Lewis SJ, Jones MI. Expression of HIV-1 gp120 and human soluble CD4 by recombinant baculoviruses and their interaction in vitro. AIDS Res Hum Retroviruses 1990; 6:76573.
  • 23
    Wang YH, Davies AH, Jones IM. Expression and purification of glutathione S-transferase-tagged HIV-1 gp120: no evidence of an interaction with CD26. Virology 1995; 208:1426.
  • 24
    MichellBE, ShiigiSM (eds). Preparation of mouse cell suspension. In: Selected Method in Cellular Immunology. New York: W.H. Freeman and company, 1980:234.
  • 25
    Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991; 145:18592.
  • 26
    Ang OO, Lin H, Dagarag M, Ng HL, Effros RB, Uittenbogaart CH. Decreased perforin and granzyme B expression in senescent HIV-1-specific cytotoxic T lymphocytes. Virology 2005; 332:169.
  • 27
    Appay V, Nixon DF, Donahoe SM et al. HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:6375.
  • 28
    Wodarz D, Jansen VA. The role of T cell help for anti-viral CTL responses. J Theor Biol 2001; 211:41932.
  • 29
    Castellino F, Germain RN. Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol 2006; 24:51940.
  • 30
    Chehimi J, Starr SE, Frank I, D’Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994; 179:13616.
  • 31
    Chougnet C, Wynn TA, Clerici M et al. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996; 174:4653.
  • 32
    Kawamura T, Gatanaga H, Borris DL, Connors M, Mitsuya H, Blauvelt A. Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells. J Immunol 2003; 170:42606.
  • 33
    Bailer RT, Holloway A, Sun J, Margolick JB, Martin M, Kostman J, Montaner LJ. IL-13 and IFN-γ secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. J Immunol 1999; 162:753442.
  • 34
    Kostense S, Vandenberghe K, Joling J, Van Baarle D, Nanlohy N, Manting E, Miedema F. Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS. Blood 2002; 99:250511.
  • 35
    Boyer JD, Cohen AD, Ugen KE et al. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. AIDS 2000; 14: 151522.
  • 36
    Fan Z, Huang XL, Borowski L, Mellors JW, Rinaldo CR Jr. Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein loaded dendritic cells. J Virol 2001; 75:44139.
  • 37
    Hodge-Dufour J, Marino MW, Horton MR. et al. Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A 1998; 95: 1380611.
  • 38
    Kennedy M, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996; 26:3708.
  • 39
    Kelsall BL, Stuber E, Neurath M, Strober W. Interleukin-12 production by dendritic cells. The role of CD40–CD40L interactions in Th1 T-cell responses. Ann N Y Acad Sci 1996; 795:11626.
  • 40
    Stuber E, Strober W, Neurath M. Blocking the CD40L–CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996; 183:6938.
  • 41
    Vanham G, Penne L, Devalck J, Kestens L, Colebunders R, Bosmans E, Thielemans K, Ceuppens JL. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol 1999; 117:33542.
  • 42
    Gorbachev AV, Fairchild RL. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12. J Immunol 2004; 173:244352.
  • 43
    Jacobson MA, Hardy D, Conninck E, Watson J, Debruin M. Phase I trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus infected patients with 100–500 CD4 cells/microL. J Infect Dis 2000; 182:10706.
  • 44
    Jacobson MA, Spritzler J, Landay A et al. AACTG 325 protocol team. A phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS 2002; 16:114754.
  • 45
    Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Yarchoan R. Activity of subcutaneous interleukin-12 in AIDS related Kaposi sarcoma. Blood 2006; 107:46507.
  • 46
    Salazar-Gonzalez JF, Martinez-Maza O, Nishanian P et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis 1998; 178:42343.